Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
CALL
Revvity
RVTY
$14.5B
| $12.4M | 0.01% |
87,100
-29,900
| -26% | -$4.48M |
|
|
SGEN
1752
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.4M | 0.01% |
70,000
-55,000
| -44% | -$7.93M |
|
1753
Bruker
BRKR
$9.03B
| $12.4M | 0.01% |
197,337
-302,497
| -61% | -$18.5M |
|
1754
Skywest
SKYW
$3.84B
| $12.4M | 0.01% |
582,516
+207,329
| +55% | +$5.44M |
|
|
CWEN.A
1755
DELISTED
Clearway Energy Class A
CWEN.A
| $12.4M | 0.01% |
386,753
+26,414
| +7% | +$823K |
|
1756
PUT
Kimberly-Clark
KMB
$36.6B
| $12.4M | 0.01% |
91,400
-190,900
| -68% | -$25.1M |
|
|
TSPQ
1757
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
| $12.3M | 0.01% |
1,266,271
+192,875
| +18% | +$1.88M |
|
|
CD
1758
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $12.3M | 0.01% |
1,590,768
+1,513,030
| +1,946% | +$9.75M |
|
1759
Vaxcyte
PCVX
$9.1B
| $12.3M | 0.01% |
566,116
+303,396
| +115% | +$7.02M |
|
1760
PUT
Otis Worldwide
OTIS
$27.2B
| $12.3M | 0.01% |
174,300
+133,200
| +324% | +$9.81M |
|
1761
Oaktree Specialty Lending
OCSL
$1.14B
| $12.3M | 0.01% |
626,799
-463,477
| -43% | -$9.76M |
|
1762
iShares Expanded Tech-Software Sector ETF
IGV
$15.2B
| $12.3M | 0.01% |
228,305
+148,995
| +188% | +$8.76M |
|
1763
Hancock Whitney
HWC
$6.02B
| $12.3M | 0.01% |
277,523
+156,511
| +129% | +$7.45M |
|
|
1764
CALL
Boston Scientific
BSX
$67.6B
| $12.3M | 0.01% |
330,000
-500,000
| -60% | -$20.4M |
|
|
ROSS
1765
DELISTED
Ross Acquisition Corp II
ROSS
| $12.3M | 0.01% |
1,250,441
-1,964
| -0.2% | -$19.3K |
|
1766
Rambus
RMBS
$9.88B
| $12.3M | 0.01% |
571,003
+5,646
| +1% | +$140K |
|
|
GBT
1767
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $12.3M | 0.01% |
383,959
+71,916
| +23% | +$2.11M |
|
1768
Rush Enterprises Class A
RUSHA
$8.3B
| $12.3M | 0.01% |
381,606
+262,816
| +221% | +$8.78M |
|
1769
Axcelis
ACLS
$3.78B
| $12.2M | 0.01% |
223,150
-231,211
| -51% | -$13.4M |
|
1770
e.l.f. Beauty
ELF
$6.26B
| $12.2M | 0.01% |
398,702
-428,195
| -52% | -$10.8M |
|
|
CVSA
1771
Covista Inc
CVSA
$4.79B
| $12.2M | 0.01% |
+339,992
| New | +$10.7M |
|
1772
CALL
Vertex Pharmaceuticals
VRTX
$139B
| $12.2M | 0.01% |
+43,400
| New | +$11.6M |
|
|
AKIC
1773
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
| $12.2M | 0.01% |
1,242,684
-8,510
| -0.7% | -$84K |
|
1774
Carriage Services
CSV
$544M
| $12.2M | 0.01% |
307,860
+117,436
| +62% | +$5.07M |
|
1775
Envoy Medical
COCH
$56.4M
| $12.2M | 0.01% |
1,244,990
-19,103
| -2% | -$187K |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.